Glatiramer Acetate | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Glatiramer Acetate
Health Canada Patents

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Contact Supplier

IOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.

Contact Supplier

IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Coral

Contact Supplier

ICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.

Contact Supplier

Glatiramer Acetate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

23 API Suppliers, 6 USDMF, 4 EU WC, 8 NDC API, 15 Listed Suppliers, $ API Reference Price

23 API Suppliers
6 USDMF
4 EU WC
8 NDC API
15 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

25 Drugs in Development

25 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

91 FDF Dossiers, 11 FDA Orange Book, 62 Europe, 4 Canada, 4 Australia, 3 South Africa, 7 Listed Dossiers

91 FDF Dossiers
11 FDA Orange Book
62 Europe
4 Canada
4 Australia
3 South Africa
7 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SOLUTION;SUBCUTANEOUS - 20MG/VIAL, INJECTABLE;SUBCUTANEOUS - 40MG/ML

FOR SOLUTION;SUBCUTANEOUS - 20MG/VIAL
INJECTABLE;SUBCUTANEOUS - 40MG/ML

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 13 SPI Pharma, 1 Gangwal Healthcare, 1 Pfanstiehl, 1 BASF, 2 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 1 Kerry, 2 Microlex e.U, 1 Pluviaendo, 3 Roquette, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries

1 Rochem International Inc
13 SPI Pharma
1 Gangwal Healthcare
1 Pfanstiehl
1 BASF
2 Gangwal Chemicals
1 Ingredion Pharma Solutions
1 Kerry
2 Microlex e.U
1 Pluviaendo
3 Roquette
1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
1 Shijiazhuang Huaxu Pharmaceutical
1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders, 12 Chewable & Orodispersible Aids, 10 Taste Masking, 10 Direct Compression, 7 Disintegrants & Superdisintegrants, 4 Parenteral, 3 Co-Processed Excipients, 3 Granulation, 1 Solubilizers, 1 Thickeners and Stabilizers

17 Fillers, Diluents & Binders
12 Chewable & Orodispersible Aids
10 Taste Masking
10 Direct Compression
7 Disintegrants & Superdisintegrants
4 Parenteral
3 Co-Processed Excipients
3 Granulation
1 Solubilizers
1 Thickeners and Stabilizers

DIGITAL CONTENT

223 News #PharmaBuzz

223 News #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 9 Regulatory FDF Prices, 11 Annual Reports

3 US Medicaid Prescriptions
9 Regulatory FDF Prices
11 Annual Reports

MARKET PLACE

8 APIs, 5 FDF Dossiers

8 APIs
5 FDF Dossiers

PATENTS & EXCLUSIVITIES

6 Health Canada Patents

6 Health Canada Patents

$ API Ref.Price (USD/KG) : 157,147 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

6 All

01 6Teva Canada Innovation

filter Patent Reset all filters

6 All

01 22191088

02 22702437

03 22760802

filter Product Reset all filters

6 All

01 4GLATIRAMER ACETATE

02 2Glatiramer Acetate

filter Dosage Reset all filters

6 All

01 1Powder for Solution

02 4SOLUTION

03 1Solution

filter Exp Date Reset all filters

6 All

01 22015-05-23

02 22028-11-26

03 22030-08-19

Product Main Page

01

Teva Canada Innovation

Glatiramer Acetate

PREP

Not Confirmed

Teva Canada Innovation

PREP

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2015-05-23

Date Granted : 2004-09-28

Glatiramer Acetate

Brand Name : COPAXONE

Patent Number : 2191088

Filing Date : 1995-05-23

Strength per Unit : 20 mg / vial

Dosage Form : Powder for Solution

Human Or VET : Human

Route of Administration : Subcutaneous

Patent Expiration Date : 2015-05-23

Date Granted : 2004-09-28

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Teva Canada Innovation

Glatiramer Acetate

PREP

Not Confirmed

Teva Canada Innovation

PREP

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2015-05-23

Date Granted : 2004-09-28

Glatiramer Acetate

Brand Name : COPAXONE

Patent Number : 2191088

Filing Date : 1995-05-23

Strength per Unit : 20 mg / 1ml

Dosage Form : Solution

Human Or VET : Human

Route of Administration : Subcutaneous

Patent Expiration Date : 2015-05-23

Date Granted : 2004-09-28

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Teva Canada Innovation

GLATIRAMER ACETATE

PREP

Not Confirmed

Teva Canada Innovation

PREP

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-11-26

Date Granted : 2013-06-25

GLATIRAMER ACETATE

Brand Name : COPAXONE

Patent Number : 2702437

Filing Date : 2008-11-26

Strength per Unit : 40mg / 1mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2028-11-26

Date Granted : 2013-06-25

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Teva Canada Innovation

GLATIRAMER ACETATE

PREP

Not Confirmed

Teva Canada Innovation

PREP

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-08-19

Date Granted : 2016-01-12

GLATIRAMER ACETATE

Brand Name : COPAXONE

Patent Number : 2760802

Filing Date : 2010-08-19

Strength per Unit : 40mg / 1mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2030-08-19

Date Granted : 2016-01-12

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Teva Canada Innovation

GLATIRAMER ACETATE

PREP

Not Confirmed

Teva Canada Innovation

Country

PREP

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-11-26

Date Granted : 2013-06-25

GLATIRAMER ACETATE

Brand Name : COPAXONE

Patent Number : 2702437

Filing Date : 2008-11-26

Strength per Unit : 40 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2028-11-26

Date Granted : 2013-06-25

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

Teva Canada Innovation

GLATIRAMER ACETATE

PREP

Not Confirmed

Teva Canada Innovation

Country

PREP

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-08-19

Date Granted : 2016-01-12

GLATIRAMER ACETATE

Brand Name : COPAXONE

Patent Number : 2760802

Filing Date : 2010-08-19

Strength per Unit : 40 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2030-08-19

Date Granted : 2016-01-12

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!